Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05009420 · ClinicalTrials.gov registry record · NA

Validation of Avocatin b as a Biomarker of Food Intake

A NA study, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.

Completed
Registry status
NA
Development phase
10
Enrollment target

NCT05009420: Completed NA study, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.

NCT05009420 is a NA study that has completed, run by Clinical Nutrition Research Center, Illinois Institute of Technology. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05009420, a NA study, has completed, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

The primary objectives are to * Identify avocatin b (C17 lipid) in plasma of individuals that consumed 1 avocado. * Confirm no avocation b present in the plasma of individuals that avoided avocado intake for 7 days. * Determine the effect of an overnight fast on avocation b detection.

Primary Outcome

fasting blood sample before eating a avocado compare with fasting blood sample 24 hours after consumed 1 avocado.

Interventions

  • OTHER Avocado

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2021-07-19
Est. Completion 2021-12-31
Phase NA

What the finished NCT05009420 record still lists

NCT05009420 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Avocado is the first listed.

NCT05009420 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05009420 about?

NCT05009420 is a clinical study titled "Validation of Avocatin b as a Biomarker of Food Intake". The primary objectives are to * Identify avocatin b (C17 lipid) in plasma of individuals that consumed 1 avocado. * Confirm no avocation b present in the plasma of individuals that avoided avocado intake for 7 days. * Determine the effect of an overnight fast on avocation b detection.

What is the current status of trial NCT05009420?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2021-07-19. Estimated completion is 2021-12-31.

What interventions are being tested in trial NCT05009420?

The interventions under investigation include: Avocado (OTHER).

Who is sponsoring clinical trial NCT05009420?

This trial is sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology, which has 59 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05009420's enrollment target sits among peer trials

10 1927th of 2000 higher than 26 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05009420, the US trial registry maintained by the National Library of Medicine. NCT05009420 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.